By describing the proteomic cargo of GBM cell line-derived EVs, Mallawaaratchy et al. identified EV biomarkers that are potentially associated with higher GBM invasiveness, such as Annexin A1 and Integrin ß1. The gene discussed is ANXA1; the disease is glioblastoma.